Dr. Van Brée Grégoire

Active

Private limited companyfounded 2019active for 7 yearsStaartmolenslaan 4, 1200 Sint-Lambrechts-Woluwe, BelgiumKBO/BCE: BE 0719.533.231

Summary

Dr. Van Brée Grégoire has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €18,600 and a net result of €106,701. Equity remains stable across the filed financial years (±1.7% per year). Its solvency ranks better than 15% of 20,620 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Risk analysisFollow Report Compare

Dr. Van Brée GrégoireActiveChecked score 91/100

Risk analysis Report Compare

Activity

General medical practice

NACE 86210

1 site

Size

€302,059turnover 2025

Equity: €18,600
Profit: €106,701

Financial health

91 Excellent Checked score 2025

Bankruptcy probabilitywithin 12 months: 0.1%

Structure

2025 accounts 81 days early3 deeds in the Belgian Official Gazette

Why 91raises riskEquity €18,600 (12.3% of total assets)lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 1.02, cash €49,118Figures for financial year 2025 (filed 16-05-2026)Show the evidence

Checked score

Score 2025

91 / 100

Excellent

Probability in this band: under 0.55%

Financially better than 32% of its sector peers (NACE 86, micro)

Every signal that counts is listed under Signals.

Financial strength · tick = 2024

Strong

Solvency 37-11

equity 12.3% of total assets

Liquidity 42+31

short-term debt 87.7% · cash 32.5%

Profitability 100=

return on assets 70.6%

Bankruptcy probability, 12 months

0.1% Very low

0%0.5%1.5%4%10%≥ 25%

About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,126 companies, NACE 86, micro)

Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025lowest value 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: 0.1%▲ +0.1 percentage points vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: 0.2%▲ +0.1 percentage points vs 08-2025 10-2025: 0.2%● unchanged vs 09-2025 11-2025: 0.2%● unchanged vs 10-2025 12-2025: 0.2%● unchanged vs 11-2025 01-2026: 0.2%● unchanged vs 12-2025 02-2026: 0.2%● unchanged vs 01-2026 03-2026: 0.2%● unchanged vs 02-2026 04-2026: 0.2%● unchanged vs 03-2026highest value 05-2026: 0.2%● unchanged vs 04-2026 06-2026: 0.1%▼ -0.1 percentage points vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026

Credit of up to €1,500 on 30-day terms is acceptable

Liquidity tight (current ratio 1.02, compared with 1.01 in 2024, below the usual 1.5; short-term debt: 87.7% and cash: 32.5% of total assets), and 87.7% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 16% on solvency, 11% on liquidity, 80% on profitability and 20% on growth.

The bankruptcy probability was computed on 27-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.

lowers riskraises riskneutral

Sector: Human health activities (NACE 86)

KBO

Liquidity: current ratio 1.02, cash €49,118

NBB · annual accounts

Figures for financial year 2025 (filed 16-05-2026)

NBB · annual accounts

Equity €18,600 (12.3% of total assets)

NBB · annual accounts

Weak solvency vs sector

Solvency (equity / total assets) is in the sector's weakest quartile: better than 15% of 20620 sector peers (2025).

NBB · sector comparison

Position among 20620 sector peers

Solvency

better than 15%

← weakest strongest →

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 11-05-2026, 81 days ahead of the deadline.

NBB · 7 filings

Deviation from the deadline

2025

81 days early

2024

32 days late

2023

43 days early

2022

41 days early

2021

8 days late

2020

23 days late

2019

14 days late

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 13 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 20 June (4 of the last 5 filed years within 49 days of that day).

Companies Code · seven months

Where today falls in the filing period

28-10-2026 today31-12-2026 year end31-07-2027 deadline

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

11-05-2026 Annual accounts filedfinancial year 2025 · micro…
31-12-2025 Highest result from 2019 to 2025net €106,701 ▲42.6%
01-09-2025 Annual accounts filedfinancial year 2024 · micro…

Key points

Caution: Among the weakest 16% on solvencysector median 63.0% · 20,620 companies 12.3% View
Positive: 7 profitable years in a rowprofit 2025: €106,701 7 years View
Turnover 2025first financial year filed €302,059 View

By topic

Financials

Financial year: 2025
Turnover: €302,059
Profit: €106,701
Solvency: 12.3%

Go to Financials

Timeline

Events: 10
Since: 2020
Next accounts: by 31-07-2027

22-07-2025General meeting · Director resignation
18-06-2024Annual accounts filed
20-06-2023Annual accounts filed

Go to Timeline

Company details

Sites: 1

Legal form: Private limited company
Activity: General medical practiceNACE 86210
Founded: 29-01-2019
Year ends: 31-12
Peppol: Reachable for e-invoices

Go to Company details

Key facts about Dr. Van Brée Grégoire

What is the company number of Dr. Van Brée Grégoire?: 0719.533.231. In Belgium the VAT number is the company number with BE in front: BE 0719.533.231.
Where is Dr. Van Brée Grégoire based?: The registered office is at Staartmolenslaan 4, 1200 Sint-Lambrechts-Woluwe.Company details
What does Dr. Van Brée Grégoire do?: According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. Van Brée Grégoire?: Private limited company (BV).
When was Dr. Van Brée Grégoire founded?: On 29-01-2019.
Is Dr. Van Brée Grégoire still active?: Yes, Dr. Van Brée Grégoire is an active enterprise in the KBO register.
What is the turnover of Dr. Van Brée Grégoire?: €302,059 in financial year 2025, according to the filed annual accounts.Financials
Is Dr. Van Brée Grégoire profitable?: In financial year 2025, Dr. Van Brée Grégoire made a profit of €106,701.
Where can I find the annual accounts of Dr. Van Brée Grégoire?: Dr. Van Brée Grégoire filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Van Brée Grégoire due?: By 31-07-2027, for financial year 2026.Timeline